The duration of the recommended treatment
Management of my appetite was the biggest challenge, so the medication has really just been game-changing
Potential heart benefits A study originally published in the J ournal of Experimental and Therapeutic Medicine found that some GLP-1 medications may lower the risk of heart disease
Sodium-glucose cotransporter 2 inhibitor (SGLT2i) is a class of glucose-lowering agents often compared with GLP-1 RA regarding cost-effectiveness
Glucose-dependent Insulinotropic Polypeptide (GIP) Receptor During fasting, K cells (found in the duodenum and jejunum) constitutively secrete the 42 amino acid protein GIP, which exhibits a marked increase in secretion after meals [11,12,13]
Following a 12-week low FODMAP diet intake, the participants exhibited a significant induction in circulating GLP-1 levels (increasing modestly from about 3.3 pM to 3.6 pM), significantly reduced body weight, and significantly improved IBS and gastrointestinal symptoms